Missed doses, improper injection technique, or inadequate dose escalation may contribute to suboptimal response
it also reduced the risk of death or worsening disease by 33% versus chemotherapy
Monitoring and adjustment protocols should include: Weight and vital signs at each visit (initially monthly, then quarterly) Assessment of medication tolerance and adherence Evaluation of eating behaviors and physical activity Laboratory monitoring as outlined previously Reassessment of weight-related comorbidities Realistic expectations should be established through shared decision-making
Some plans go above and beyond by offering extra resources too
This can contribute to fatigue, reduced muscle mass, menstrual irregularities in women, and decreased bone density
For example, a population-based observational study reported a higher incidence of pancreatitis among obese individuals treated with semaglutide or liraglutide compared with those receiving naltrexonebupropion